Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Nandurkar

Showing results (11-20 of 39) with videos related to

Pageof 4
Sort By:
Vascular and Endovascular Surgery|August 29, 2025
Etiology is a Factor when Choosing Endovascular or Open Treatment for Acute Mesenteric IschemiaTejas S Nandurkar, Olivia H Millay, Eric D Endean
Alimentary Pharmacology & Therapeutics|March 6, 2013
Letter: an allergic phenotype in patients with eosinophilic oesophagitis and asthmaH Philpott, P R Gibson, F Thien, et al.
Alimentary Pharmacology & Therapeutics|September 3, 2015
Letter: seasonality in eosinophilic oesophagitis and food bolus obstruction - what about recurrent episodes?H Philpott, S Nandurkar, S G Royce, et al.
Postgraduate Medical Journal|June 20, 2014
Drug-induced gastrointestinal disordersH L Philpott, S Nandurkar, J Lubel, et al.
Frontline Gastroenterology|August 26, 2017
Drug-induced gastrointestinal disordersH L Philpott, S Nandurkar, J Lubel, et al.
Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus|March 11, 1999
Curable cancer in a short segment Barrett's esophagusS Nandurkar, C J Martin, N J Talley, et al.
Alimentary Pharmacology & Therapeutics|February 13, 2009
Clinical trial: the treatment of gastro-oesophageal reflux disease in primary care--prospective randomized comparison of rabeprazole 20 mg with esomeprazole 20 and 40 mgA Eggleston, P H Katelaris, S Nandurkar, et al.
Neurogastroenterology and Motility|June 23, 2010
Physiology of diffuse esophageal spasm (DES)--when normal swallows are not normalC Krieger-Grübel, R Hiscock, S Nandurkar, et al.
Alimentary Pharmacology & Therapeutics|March 5, 2016
A prospective open clinical trial of a proton pump inhibitor, elimination diet and/or budesonide for eosinophilic oesophagitisH Philpott, S Nandurkar, S G Royce, et al.
Ultrasonics Sonochemistry|May 12, 2007
Ultrasound promoted selective synthesis of 1,1'-binaphthyls catalyzed by Fe impregnated pillared Montmorillonite K10 in presence of TBHP as an oxidantMalhari D Bhor, Nitin S Nandurkar, Mayur J Bhanushali, et al.
Pageof 4

Showing results (11-20 of 39) with videos related to

Sort By:
Pageof 4
Vascular and Endovascular Surgery|August 29, 2025
Etiology is a Factor when Choosing Endovascular or Open Treatment for Acute Mesenteric IschemiaTejas S Nandurkar, Olivia H Millay, Eric D Endean
Alimentary Pharmacology & Therapeutics|March 6, 2013
Letter: an allergic phenotype in patients with eosinophilic oesophagitis and asthmaH Philpott, P R Gibson, F Thien, et al.
Alimentary Pharmacology & Therapeutics|September 3, 2015
Letter: seasonality in eosinophilic oesophagitis and food bolus obstruction - what about recurrent episodes?H Philpott, S Nandurkar, S G Royce, et al.
Postgraduate Medical Journal|June 20, 2014
Drug-induced gastrointestinal disordersH L Philpott, S Nandurkar, J Lubel, et al.
Frontline Gastroenterology|August 26, 2017
Drug-induced gastrointestinal disordersH L Philpott, S Nandurkar, J Lubel, et al.
Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus|March 11, 1999
Curable cancer in a short segment Barrett's esophagusS Nandurkar, C J Martin, N J Talley, et al.
Alimentary Pharmacology & Therapeutics|February 13, 2009
Clinical trial: the treatment of gastro-oesophageal reflux disease in primary care--prospective randomized comparison of rabeprazole 20 mg with esomeprazole 20 and 40 mgA Eggleston, P H Katelaris, S Nandurkar, et al.
Neurogastroenterology and Motility|June 23, 2010
Physiology of diffuse esophageal spasm (DES)--when normal swallows are not normalC Krieger-Grübel, R Hiscock, S Nandurkar, et al.
Alimentary Pharmacology & Therapeutics|March 5, 2016
A prospective open clinical trial of a proton pump inhibitor, elimination diet and/or budesonide for eosinophilic oesophagitisH Philpott, S Nandurkar, S G Royce, et al.
Ultrasonics Sonochemistry|May 12, 2007
Ultrasound promoted selective synthesis of 1,1'-binaphthyls catalyzed by Fe impregnated pillared Montmorillonite K10 in presence of TBHP as an oxidantMalhari D Bhor, Nitin S Nandurkar, Mayur J Bhanushali, et al.
Pageof 4